Please login to the form below

Not currently logged in
Email:
Password:

Dr Richard Barker joins Celgene's board of directors

Former ABPI director general takes up second new post this month

Richard Barker - CelgeneFormer director general of the Association of the British Pharmaceutical Industry (ABPI) Dr Richard Barker has been elected to the board of directors at Celgene.

He spent almost seven years at ABPI's helm, stepping down in May last year when he was succeeded by Stephen Whitehead.

It is Barker's second recent appointment after he joined authentication and traceability services company Aegate earlier this month as a senior adviser.

Prior to his post leading the ABPI, Barker's career included serving as chief executive of Chiron Diagnostics, general manager of IBM's Worldwide Healthcare Solutions division and leader of McKinsey & Company's European healthcare practice.

Robert Hugin, Celgene's chairman and CEO, said: “As we continue to expand our global reach, Dr Barker's international perspective will enhance our ability to navigate through an increasingly dynamic healthcare landscape and provide patients access to our innovative therapies.”

The US biopharmaceutical company focuses on developing and commercialising novel treatments for cancer and inflammatory diseases.

Its top-selling product is Revlimid, which suffered a setback last November after a phase III prostate cancer trial found no overall survival benefit.

Nevertheless, the drug is still expected to account for around $3bn of the firm's 2011 sales.

24th January 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics